Ontario Clinical Oncology Group (ocog)

This study looks at whether women with early-stage breast cancer who have a complete response to chemotherapy can safely avoid radiation after lumpectomy. About 352 women whose cancer has not spread to lymph nodes will be enrolled. The goal is to see if skipping radiation keeps t…

This study looks at men whose prostate cancer has come back in a few spots after radiation therapy. It tests whether adding a hormone-blocking drug (ELIGARD) to targeted treatment helps keep the cancer from growing longer than targeted treatment alone. About 162 men will take par…

This study compares a 1-week course of partial breast radiation to standard whole breast radiation in women with early-stage breast cancer. The goal is to see if the shorter treatment is just as effective at preventing cancer from coming back and causes fewer cosmetic side effect…

This study tests a new way of giving the drug elranatamab to people with multiple myeloma that has come back or stopped responding to other treatments. The goal is to see if giving the drug in an outpatient setting and on a less frequent schedule can reduce hospital stays and ser…

This study looks at whether women over 45 with a low-risk type of early breast cancer called DCIS can avoid radiation after surgery. Doctors use a genetic test (Oncotype DX) along with other factors to identify those with a very low chance of the cancer coming back. The goal is t…